{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T17:55:20Z","timestamp":1767808520571,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Swiss Parkinson Foundation Research Grant"},{"name":"Synapsis Foundation Research Grant","award":["2022-PI06"],"award-info":[{"award-number":["2022-PI06"]}]},{"name":"AFRI-EOC Research Support"},{"name":"SEED4IP, the Ministry of Enterprises and Made in Italy (MIMIT),"},{"name":"RECOGNIZED, the European Commission\u2019s Horizon 2020 research and innovation program","award":["847749"],"award-info":[{"award-number":["847749"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01224-4","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T11:55:54Z","timestamp":1765367754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["JNK3 quantification in plasma: a novel biomarker for neuronal damage in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Elena","family":"Vacchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Giani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nunzio","family":"Perta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Turchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Pasetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Bonetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Giulia","family":"Bacalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Provini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Hackethal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Miano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Manconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"K\u00e4gi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Bertaina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Galati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Kaelin-Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Raimondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariaelena","family":"Repici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Tettamanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Melli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Borsello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"1224_CR1","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/S2666-7568(24)00094-1","volume":"5","author":"J Zhu","year":"2024","unstructured":"Zhu, J. et al. Temporal trends in the prevalence of Parkinson\u2019s disease from 1980 to 2023: a systematic review and meta-analysis. Lancet Healthy Longev. 5, e464\u2013e479 (2024).","journal-title":"Lancet Healthy Longev."},{"key":"1224_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"1224_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger, G. U. et al. A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol. 23, 191\u2013204 (2024).","journal-title":"Lancet Neurol."},{"key":"1224_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni, T. et al. A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 23, 178\u2013190 (2024).","journal-title":"Lancet Neurol."},{"key":"1224_CR5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"1224_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mds.25249","volume":"28","author":"AB Singleton","year":"2013","unstructured":"Singleton, A. B., Farrer, M. J. & Bonifati, V. The genetics of Parkinson\u2019s disease: progress and therapeutic implications. Mov. Disord. 28, 14\u201323 (2013).","journal-title":"Mov. Disord."},{"key":"1224_CR7","doi-asserted-by":"publisher","first-page":"106078","DOI":"10.1016\/j.parkreldis.2024.106078","volume":"122","author":"A Chopra","year":"2024","unstructured":"Chopra, A., Lang, A. E., H\u00f6glinger, G. & Outeiro, T. F. Towards a biological diagnosis of PD. Parkinsonism Relat. Disord. 122, 106078 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1224_CR8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"1224_CR9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","volume":"20","author":"F Stocchi","year":"2024","unstructured":"Stocchi, F., Bravi, D., Emmi, A. & Antonini, A. Parkinson disease therapy: current strategies and future research priorities. Nat. Rev. Neurol. 20, 695\u2013707 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"1224_CR10","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2024.0792","volume":"331","author":"CH Gibbons","year":"2024","unstructured":"Gibbons, C. H. et al. Skin biopsy detection of phosphorylated \u03b1-synuclein in patients with synucleinopathies. JAMA 331, 1298 (2024).","journal-title":"JAMA"},{"key":"1224_CR11","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/acn3.669","volume":"5","author":"G Melli","year":"2018","unstructured":"Melli, G. et al. Cervical skin denervation associates with alpha-synuclein aggregates in Parkinson disease. Ann. Clin. Transl. Neurol. 5, 1394\u20131407 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1224_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41531-021-00262-y","volume":"7","author":"E Vacchi","year":"2021","unstructured":"Vacchi, E. et al. Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson\u2019s disease. NPJ Parkinsons Dis. 7, 119 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"1224_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41531-024-00768-1","volume":"10","author":"CC Pedersen","year":"2024","unstructured":"Pedersen, C. C. et al. Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson\u2019s Disease. NPJ Parkinsons Dis. 10, 162 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1224_CR14","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/mds.28206","volume":"35","author":"B Mollenhauer","year":"2020","unstructured":"Mollenhauer, B. et al. Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression. Mov. Disord. 35, 1999\u20132008 (2020).","journal-title":"Mov. Disord."},{"key":"1224_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3233\/JPD-212866","volume":"12","author":"E Ygland R\u00f6dstr\u00f6m","year":"2022","unstructured":"Ygland R\u00f6dstr\u00f6m, E., Mattsson-Carlgren, N., Janelidze, S., Hansson, O. & Puschmann, A. Serum neurofilament light chain as a marker of progression in parkinson\u2019s disease: long-term observation and implications of clinical subtypes. J. Parkinsons Dis. 12, 571\u2013584 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1224_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1128\/MMBR.00043-14","volume":"80","author":"A Zeke","year":"2016","unstructured":"Zeke, A., Misheva, M., Rem\u00e9nyi, A. & Bogoyevitch, M. A. JNK signaling: regulation and functions based on complex protein-protein partnerships. Microbiol. Mol. Biol. Rev. 80, 793\u2013835 (2016).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1224_CR17","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3390\/cells9102190","volume":"9","author":"CA Musi","year":"2020","unstructured":"Musi, C. A., Agr\u00f2, G., Santarella, F., Iervasi, E. & Borsello, T. JNK3 as therapeutic target and biomarker in neurodegenerative and neurodevelopmental brain diseases. Cells 9, 2190 (2020).","journal-title":"Cells"},{"key":"1224_CR18","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.neuron.2012.06.024","volume":"75","author":"SO Yoon","year":"2012","unstructured":"Yoon, S. O. et al. JNK3 perpetuates metabolic stress induced by a\u03b2 peptides. Neuron 75, 824\u2013837 (2012).","journal-title":"Neuron"},{"key":"1224_CR19","first-page":"6986","volume":"24","author":"NK Genabai","year":"2015","unstructured":"Genabai, N. K. et al. Genetic inhibition of JNK3 ameliorates spinal muscular atrophy. Hum Mol Genet. 24, 6986\u20137004 (2015).","journal-title":"Hum Mol Genet."},{"key":"1224_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/39899","volume":"389","author":"DD Yang","year":"1997","unstructured":"Yang, D. D. et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865\u2013870 (1997).","journal-title":"Nature"},{"key":"1224_CR21","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S1359-6446(04)03251-9","volume":"9","author":"L Resnick","year":"2004","unstructured":"Resnick, L. & Fennell, M. Targeting JNK3 for the treatment of neurodegenerative disorders. Drug Discov. Today 9, 932\u2013939 (2004).","journal-title":"Drug Discov. Today"},{"key":"1224_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1167\/iovs.14-15539","volume":"56","author":"SK Chintala","year":"2015","unstructured":"Chintala, S. K., Putris, N. & Geno, M. Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3. Invest Ophthalmol. Vis. Sci. 56, 505\u2013514 (2015).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"1224_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0669-1","author":"L de Lemos","year":"2017","unstructured":"de Lemos, L. et al. Neuroprotective effects of the absence of JNK1 or JNK3 isoforms on kainic acid-induced temporal lobe epilepsy-like symptoms. Mol. Neurobiol. https:\/\/doi.org\/10.1007\/s12035-017-0669-1 (2017).","journal-title":"Mol. Neurobiol."},{"key":"1224_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrn3729","volume":"15","author":"ET Coffey","year":"2014","unstructured":"Coffey, E. T. Nuclear and cytosolic JNK signalling in neurons. Nat. Rev. Neurosci. 15, 285\u2013299 (2014).","journal-title":"Nat. Rev. Neurosci."},{"key":"1224_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1073\/pnas.0307453101","volume":"101","author":"S Hunot","year":"2004","unstructured":"Hunot, S. et al. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson\u2019s disease. Proc. Natl. Acad. Sci. 101, 665\u2013670 (2004).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1224_CR26","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.7120","author":"Y Chen","year":"2018","unstructured":"Chen, Y., Zheng, X., Wang, Y. & Song, J. Effect of PI3K\/Akt\/mTOR signaling pathway on JNK3 in Parkinsonian rats. Exp. Ther. Med. https:\/\/doi.org\/10.3892\/etm.2018.7120 (2018).","journal-title":"Exp. Ther. Med."},{"key":"1224_CR27","doi-asserted-by":"publisher","first-page":"e0119204","DOI":"10.1371\/journal.pone.0119204","volume":"10","author":"J Pan","year":"2015","unstructured":"Pan, J. et al. Small Peptide Inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway. PLoS ONE 10, e0119204 (2015).","journal-title":"PLoS ONE"},{"key":"1224_CR28","doi-asserted-by":"publisher","unstructured":"Shuai, W. et al. Selective covalent inhibiting JNK3 by small molecules for Parkinson\u2019s diseases. Angew. Chem. Int. Edn. 63, https:\/\/doi.org\/10.1002\/anie.202411037 (2024).","DOI":"10.1002\/anie.202411037"},{"key":"1224_CR29","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1021\/acs.jmedchem.2c01410","volume":"66","author":"W Shuai","year":"2023","unstructured":"Shuai, W. et al. Discovery of novel indazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Parkinson\u2019s disease. J. Med Chem. 66, 1273\u20131300 (2023).","journal-title":"J. Med Chem."},{"key":"1224_CR30","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.2741\/4517","volume":"22","author":"A Camins","year":"2017","unstructured":"Camins, A. Role of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegeneration. Front. Biosci. 22, 4517, https:\/\/doi.org\/10.2741\/4517 (2017).","journal-title":"Front. Biosci."},{"key":"1224_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1503\/jpn.140062","volume":"40","author":"S Gourmaud","year":"2015","unstructured":"Gourmaud, S. et al. Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline. J. Psychiatry Neurosci. 40, 151\u2013161 (2015).","journal-title":"J. Psychiatry Neurosci."},{"key":"1224_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336918.2024.2316576","volume":"18","author":"Y Wu","year":"2024","unstructured":"Wu, Y. et al. JNK3 inhibitors as promising pharmaceuticals with neuroprotective properties. Cell Adh. Migr. 18, 1\u201311 (2024).","journal-title":"Cell Adh. Migr."},{"key":"1224_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-020-00406-3","volume":"15","author":"E Zucchi","year":"2020","unstructured":"Zucchi, E. et al. Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Mol. Neurodegener. 15, 58 (2020).","journal-title":"Mol. Neurodegener."},{"key":"1224_CR34","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00702-023-02632-7","volume":"130","author":"C Buhmann","year":"2023","unstructured":"Buhmann, C., Magnus, T. & Choe, C.-U. Blood neurofilament light chain in Parkinson\u2019s disease. J. Neural Transm. (Vienna) 130, 755\u2013762 (2023).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"1224_CR35","doi-asserted-by":"publisher","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","volume":"93","author":"C-H Lin","year":"2019","unstructured":"Lin, C.-H. et al. Blood NfL: A biomarker for disease severity and progression in Parkinson disease. Neurology 93, e1104\u2013e1111 (2019).","journal-title":"Neurology"},{"key":"1224_CR36","doi-asserted-by":"publisher","unstructured":"Li, Y. et al. c-Jun N-terminal kinase signaling in aging. Front Aging Neurosci. 16, https:\/\/doi.org\/10.3389\/fnagi.2024.1453710 (2024).","DOI":"10.3389\/fnagi.2024.1453710"},{"key":"1224_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41531-024-00813-z","volume":"10","author":"B Orso","year":"2024","unstructured":"Orso, B. et al. Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [18F]FDG-PET study. NPJ Parkinsons Dis. 10, 200 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1224_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41531-024-00655-9","volume":"10","author":"SE Holmes","year":"2024","unstructured":"Holmes, S. E. et al. Synaptic loss and its association with symptom severity in Parkinson\u2019s disease. NPJ Parkinsons Dis. 10, 42 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1224_CR39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/mds.29287","volume":"38","author":"J Nilsson","year":"2023","unstructured":"Nilsson, J. et al. Cerebrospinal fluid biomarkers of synaptic dysfunction are altered in Parkinson\u2019s disease and related disorders. Movement Disord. 38, 267\u2013277 (2023).","journal-title":"Movement Disord."},{"key":"1224_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181\u2013184 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1224_CR41","unstructured":"American Academy of Sleep Medicine (AASM). International Classification of Sleep Disorders 3rd edn. (ICSD-3). AASM International Classification of Sleep Disorders, 3rd ed, text revision (ICSD-3-TR) https:\/\/aasm.org\/clinical-resources\/international-classification-sleep-disorders (2023)."},{"key":"1224_CR42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn, M. M. & Yahr, M. D. Parkinsonism: onset, progression and mortality. Neurology 17, 427\u2013442 (1967).","journal-title":"Neurology"},{"key":"1224_CR43","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"1224_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189\u2013198 (1975).","journal-title":"J. Psychiatr. Res."},{"key":"1224_CR45","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695\u2013699 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1224_CR46","doi-asserted-by":"publisher","DOI":"10.1037\/t00742-000","author":"AT Beck","year":"2011","unstructured":"Beck, A. T., Steer, R. A. & Brown, G. Beck Depression Inventory\u2013II. PsycTESTS Dataset https:\/\/doi.org\/10.1037\/t00742-000 (2011).","journal-title":"PsycTESTS Dataset"},{"key":"1224_CR47","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","volume":"87","author":"DM Sletten","year":"2012","unstructured":"Sletten, D. M., Suarez, G. A., Low, P. A., Mandrekar, J. & Singer, W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin. Proc. 87, 1196\u20131201 (2012).","journal-title":"Mayo Clin. Proc."},{"key":"1224_CR48","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","volume":"22","author":"K Stiasny-Kolster","year":"2007","unstructured":"Stiasny-Kolster, K. et al. The REM sleep behavior disorder screening questionnaire-a new diagnostic instrument. Mov. Disord. 22, 2386\u20132393 (2007).","journal-title":"Mov. Disord."},{"key":"1224_CR49","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson, C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov. Disord. 25, 2649\u20132653 (2010).","journal-title":"Mov. Disord."},{"key":"1224_CR50","doi-asserted-by":"publisher","unstructured":"Chen H., Zhou Y., Liu Y., Zhang P. & Chen M. Network integration and protein structural binding analysis of neurodegeneration-related interactome. Brief Bioinform. 24, https:\/\/doi.org\/10.1093\/bib\/bbad237 (2023).","DOI":"10.1093\/bib\/bbad237"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01224-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:03:51Z","timestamp":1767801831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01224-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1224"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01224-4","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}